Document Type
Article
Publication Date
2-12-2013
Publication Title
PLoS Medicine
Department
Geisel School of Medicine
Abstract
Atypical antipsychotic medications are widely prescribed for the adjunctive treatment of depression, yet their total risk-benefit profile is not well understood. We thus conducted a systematic review of the efficacy and safety profiles of atypical antipsychotic medications used for the adjunctive treatment of depression.
DOI
10.1371/journal.pmed.1001403
Original Citation
Spielmans GI, Berman MI, Linardatos E, Rosenlicht NZ, Perry A, Tsai AC. Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes. PLoS Med. 2013;10(3):e1001403. doi: 10.1371/journal.pmed.1001403. Epub 2013 Mar 12. PMID: 23554581; PMCID: PMC3595214.
Dartmouth Digital Commons Citation
Spielmans, Glen I.; Berman, Margit I.; Linardatos, Eftihia; and Rosenlicht, Nicholas. Z., "Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes" (2013). Dartmouth Scholarship. 1573.
https://digitalcommons.dartmouth.edu/facoa/1573
